Diabetes care
-
Randomized Controlled Trial Multicenter Study Clinical Trial
Beneficial effects of viscous dietary fiber from Konjac-mannan in subjects with the insulin resistance syndrome: results of a controlled metabolic trial.
Dietary fiber has recently received recognition for reducing the risk of developing diabetes and heart disease. The implication is that it may have therapeutic benefit in prediabetic metabolic conditions. To test this hypothesis, we investigated the effect of supplementing a high-carbohydrate diet with fiber from Konjac-mannan (KJM) on metabolic control in subjects with the insulin resistance syndrome. ⋯ A diet rich in high-viscosity KJM improves glycemic control and lipid profile, suggesting a therapeutic potential in the treatment of the insulin resistance syndrome.
-
Comparative Study Clinical Trial Controlled Clinical Trial
Effect of physician specialty on outcomes in diabetic ketoacidosis.
More than 100,000 people are hospitalized annually in the U.S. with diabetic ketoacidosis (DKA). Outcome differences have not been examined for these patients based on whether their primary care provider is a generalist or a diabetes specialist. The objective of this study was to investigate hospital charges and hospital length of stay (LOS) for patients with DKA according to the specialty of their primary care provider. ⋯ Endocrinologists provide more cost-effective care than generalists do when serving as primary care providers for patients hospitalized with DKA.
-
Clinical Trial Controlled Clinical Trial
Short needles (8 mm) reduce the risk of intramuscular injections in children with type 1 diabetes.
To study whether 8-mm needles can reduce the frequency of intramuscular injections in diabetic children. ⋯ Needles that are 8 mm long significantly reduce the risk of intramuscular insulin injection in slim or normal-weight (BMI < or = 60th percentile) diabetic children and adolescents.